Article
TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions.
American journal of human genetics - 1 Dec 2022
Hijazi Hadia, Reis Linda M, Pehlivan Davut, Bernstein Jonathan A, Muriello Michael, Syverson Erin, Bonner Devon, Estiar Mehrdad A, Gan-Or Ziv, Rouleau Guy A, Lyulcheva Ekaterina, Greenhalgh Lynn, Tessarech Marine, Colin Estelle, Guichet Agnès, Bonneau Dominique, van Jaarsveld R H, Lachmeijer A M A, Ruaud Lyse, Levy Jonathan, Tabet Anne-Claude, Ploski Rafal, Rydzanicz Małgorzata, Kępczyński Łukasz, Połatyńska Katarzyna, Li Yidan, Fatih Jawid M, Marafi Dana, Rosenfeld Jill A, Coban-Akdemir Zeynep, Bi Weimin, Gibbs Richard A, Hobson Grace M, Hunter Jill V, Carvalho Claudia M B, Posey Jennifer E, Semina Elena V, Lupski James R
Abstract excerpt
An Xq22.2 region upstream of PLP1 has been proposed to underly a neurological disease trait when deleted in 46,XX females. Deletion mapping revealed that heterozygous deletions encompassing the smallest region of overlap (SRO) spanning six Xq22.2 genes (BEX3, RAB40A, TCEAL4, TCEAL3, TCEAL1, and MORF4L2) associate with an early-onset neurological disease trait (EONDT) consisting of hypotonia, intellectual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
